Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Multi-month supply purchases
Ongoing monitoring : Regular reviews in line with local Tier 3/4 weight management service protocols
Semaglutide, a single-pathway GLP-1 receptor agonist delivered as a weekly subcutaneous injection, positioned by the brand as the most-proven, lowest-entry-cost option
Why Choose Glutocred
A healthcare provider may prescribe them if theres a shortage or the patient needs a custom dose or formulation that isnt commercially available
No notifications yet Sun Pharmaceutical Industries Limited announced that it has received approval from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide injection in South Africa for the treatment of adults with inadequately controlled type 2 diabetes mellitus as an adjunct to diet and exercise
US$ 29.10
US$ 20.61
US$ 26.73
US$ 29.43
US$ 24.39
US$ 21.03
US$ 28.67
